| Title |
Author |
Type |
Date |
Words |
| Hong Kong : CSL, SIMtone Ink Exclusive Licensing Agreement to Develop Cloud Computing Services. |
|
|
Dec 8, 2009 |
411 |
| BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. |
|
|
Nov 13, 2009 |
510 |
| Can-Fite BioPharma Expands its Pipeline by Licensing Allosteric Modulators from Leiden University and the NIH. |
|
|
Jul 28, 2009 |
536 |
| Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection. |
|
|
Apr 21, 2009 |
1663 |
| StemCells, Inc. Announces License Agreement with Major Pharmaceutical Company Covering Gene Insertion Technology. |
|
|
Apr 16, 2009 |
812 |
| Research and Markets: Evolving Trends in Biopharmaceutical Licensing - Deal Assessments, Drivers and Resistors. |
|
|
Apr 6, 2009 |
869 |
| Australia : AVI BioPharma signs licensing agreement with University of Western Australia. |
|
|
Nov 28, 2008 |
186 |
| Taiwan: Cel-Sci expands licensing agreement with Orient Europharma. |
|
|
Nov 7, 2008 |
212 |
| India: BSV signs licensing and supply agreement with Actavis. |
|
|
Oct 3, 2008 |
155 |
| Helix BioMedix Announces License Agreement with Rodan & Fields, LLC. |
|
Clinical report |
Sep 3, 2008 |
892 |
| United States: Canopus BioPharma signs license agreement with Wisconsin Research Foundation. |
|
|
Jun 21, 2008 |
154 |
| Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement with Wisconsin Alumni Research Foundation. |
|
|
Jun 18, 2008 |
534 |
| BioInvent and ThromboGenics Announce a Strategic Alliance with Roche for TB-403, A Novel Anti-Cancer Antibody. |
|
|
Jun 18, 2008 |
1395 |
| United States: MorphoSys, OncoMed Extend Licensing Agreement for Two Years. |
|
|
Jun 17, 2008 |
113 |
| Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation. |
|
|
Jun 1, 2008 |
519 |
| Cord blood bank infuses clinical trials with cash: StemCyte to work with Rutgers on taking process to market. |
Crowe, Deborah |
Brief article |
Mar 3, 2008 |
312 |
| Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V. |
|
|
Feb 29, 2008 |
612 |
| CryoLife, Trophic Solutions, LLC sign agreement to develop organ transplant solution to extend kidney storage times. |
|
|
Feb 1, 2008 |
167 |
| mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical. |
|
|
Feb 1, 2008 |
479 |
| BioTime Licenses Human Embryonic Stem Cell Technology from the Wisconsin Alumni Research Foundation. |
|
|
Jan 9, 2008 |
779 |
| CryoLife Announces Worldwide Organ Transport Solution License Agreement With Trophic Solutions. |
|
|
Jan 1, 2008 |
597 |
| Medimmune, Microsoft, and KSR: the United States Supreme Court in 2007 tips the balance in favor of innovation in patent cases, and thrice reverses the Federal Circuit. |
Mota, Sue Ann |
|
Jan 1, 2008 |
7577 |
| Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents. |
|
|
Nov 20, 2007 |
1037 |
| Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases. |
|
|
Nov 7, 2007 |
808 |
| Inhibitex Licenses HIV Integrase Inhibitor Program. |
|
|
Sep 11, 2007 |
1456 |
| Pharmexa and Affitech Enter into an Exclusive License Agreement to Promote Diabody Technology. |
|
|
Apr 3, 2007 |
272 |
| Start Licensing Grants License Rights to GTC Biotherapeutics. |
|
|
Apr 1, 2007 |
308 |
| Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement. |
|
|
Mar 13, 2007 |
765 |
| GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R). |
|
|
Mar 13, 2007 |
874 |
| Astex grants cytochrome P450 license to Glaxosmithkline. |
|
|
Mar 1, 2007 |
544 |
| U.S. Supreme Court Decision Permits Patent Challenges By Licensees. |
|
|
Jan 24, 2007 |
605 |
| Licensees May Challenge A Patent Without Breaching License. |
|
Case overview |
Jan 15, 2007 |
1042 |
| The Supreme Court Decides That A Patent Licensee Need Not Breach The License Before Challenging The Licensed Patent. |
|
|
Jan 12, 2007 |
2398 |
| Patent Licensee In Good Standing Can Challenge Patent Under Declaratory Judgment Act. |
|
|
Jan 12, 2007 |
1015 |
| Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40. |
|
|
Jan 8, 2007 |
1075 |
| Ambrilia Biopharma and Merck & Co., Inc. Sign Licensing Agreement Granting Merck Worldwide Rights to Ambrilia's HIV/AIDS Protease Inhibitor Program. |
|
|
Oct 12, 2006 |
1140 |
| AVANT Announces Latest GSK Report on Sales of Rotarix(R) Evidences Disagreement on Royalty Rate in Patent Countries. |
|
|
Sep 20, 2006 |
834 |
| Biogen Idec and mondoBIOTECH Sign Collaboration and Licensing Agreement to Develop and Commercialize Aviptadil for Pulmonary Arterial Hypertension. |
|
|
Sep 14, 2006 |
891 |
| InViragen announces exclusive patent license agreement with CDC. |
|
|
Sep 1, 2006 |
520 |
| StemCells, Inc. Grants License to Stem Cell Therapeutics. |
|
|
Aug 29, 2006 |
1061 |
| Enzo Biochem Announces Plans to Produce Single Copy DNA Probes That Could Open Door to More Effective Treatment of Genetic Diseases and Cancer. |
|
|
May 23, 2006 |
1012 |
| Supreme Court Docket Report - October Term, 2005-No. 9. |
|
|
Mar 3, 2006 |
1231 |
| AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron. |
|
|
Jan 27, 2006 |
682 |
| Amgen and Genentech Sign License Agreements For Antibody Patents. |
|
|
Jan 26, 2006 |
280 |
| Chemicon International, Inc. Enters into License Agreement with RheoGene, Inc. to Commercialize Research Products Utilizing RheoSwitch(R) Inducible Gene Regulation Technology. |
|
Company Profile |
Nov 28, 2005 |
806 |
| Atrium Medical, Isotechnika announce licensing agreements for use of new drugs with medical devices. |
|
Brief Article |
Oct 15, 2005 |
181 |
| BioVeris licenses vaccine portfolio from Baxter. |
|
|
Jul 1, 2005 |
339 |
| Chiron, Enanta Pharmaceuticals sign agreement for developing, commercializing HCV therapeutics. |
|
Brief Article |
May 23, 2005 |
122 |
| Applied Biosystems and Roche settle lawsuits and expand PCR licensing. |
|
Brief Article |
May 15, 2005 |
192 |
| Martek, Kellogg sign licensing agreement. |
|
Brief Article |
Mar 1, 2005 |
91 |
| Abgenix and Genentech extend antibody technology licensing agreement. |
|
|
Mar 1, 2005 |
342 |
| Chiron, LabCorp sign HCV nucleic acid testing agreement. |
|
Brief Article |
Dec 15, 2004 |
103 |
| Corgentech licenses peptide delivery system from Cyclacel. |
|
|
Sep 1, 2004 |
538 |
| Viragen licenses Oxford BioMedica's LentiVector gene delivery system for use in Avian Transgenics biomanufacturing program. |
|
|
Jul 1, 2004 |
654 |
| AspenBio signs exclusive license with Washington University for reproductive patent estate. |
|
|
May 1, 2004 |
576 |
| Abbott, Corixa enter into agreement for Chagas' disease blood screening technology. |
|
Brief Article |
Apr 16, 2004 |
164 |
| Scotland awards grant to Viragen for cancer research. |
|
|
Apr 1, 2004 |
510 |
| Aventis and Intercell form bacterial vaccine collaboration. |
|
|
Mar 1, 2004 |
382 |
| Roche Diagnostics licensed Incyte's Eberwine linear RNA amplification technology. |
|
Brief Article |
Feb 15, 2004 |
30 |
| Protein Design Labs receives license fees for humanized antibodies. |
|
|
Feb 1, 2004 |
388 |
| Therion Biologics obtains rights to Biogen Idec LFA-3. |
|
|
Jan 1, 2004 |
389 |
| Genentech and Protein Design Labs settle antibody patent dispute. |
|
|
Dec 1, 2003 |
461 |
| Biogen. |
|
Brief Article |
Oct 1, 2003 |
53 |
| Chiron grants non-exclusive HCV license to Pfizer. |
|
|
Oct 1, 2003 |
329 |
| diaDexus forms diagnostic license agreements with Human Genome Sciences. |
|
Brief Article |
Oct 1, 2003 |
218 |
| VaxGen finalizes commercial rights to anthrax vaccine. |
|
|
Oct 1, 2003 |
406 |
| Protein Design Labs and Genentech extend antibody agreement. |
|
|
Sep 1, 2003 |
314 |
| StemCells grants license to StemCell Technologies to studyneural stem cells. |
|
|
Sep 1, 2003 |
445 |
| Quintiles Transnational. |
|
Brief Article |
Sep 1, 2003 |
79 |
| Human Genome Sciences licenses human gene technology to Genentech. |
|
Brief Article |
Aug 1, 2003 |
233 |
| SYN X acquires non-exclusive rights from Roche Diagnostics to NT-proBNP. |
|
|
Jul 1, 2003 |
920 |
| Gen-Probe nucleic acid test for West Nile Virus now available. |
|
|
Jun 1, 2003 |
519 |
| Biogen licenses immunoadheson patents from Genentech. |
|
Brief Article |
Jun 1, 2003 |
124 |
| Valentis licenses delivery technology to Juvaris. |
|
|
May 1, 2003 |
471 |
| Protein Design Labs licenses development rights to leukemia antibody. |
|
|
Mar 1, 2003 |
530 |
| diaDexus exclusively licenses rights related to Testisin. |
|
|
Feb 1, 2003 |
144 |
| Affymetrix hits $70 million clinical payday. (Executive briefing: news, trends & market intelligence for instrument executives). |
|
Brief Article |
Jan 31, 2003 |
174 |
| Cell Genesys receives $15 million license fee from Transkaryotic Therapies. |
|
|
Jan 1, 2003 |
396 |
| Random samples: companies. |
|
|
Dec 31, 2002 |
486 |
| GeneLink, MedQuest execute licensing agreement. (Industry News). |
|
Brief Article |
Sep 1, 2002 |
60 |
| Diversa granted United States patent covering sequence-based screening. |
|
Brief Article |
Sep 1, 2002 |
444 |
| BioVex signs exclusive licence to use key antigens in vaccine. |
|
Brief Article |
Sep 1, 2002 |
631 |
| AMT licenses rights on IL-10 for ex-vivo gene therapy. |
|
Brief Article |
Aug 1, 2002 |
410 |
| Evotec grants gene fragment patent licence to Roche Diagnostics. |
|
Brief Article |
Aug 1, 2002 |
433 |
| MedImmune licenses rights to human metapneumovirus. |
|
Brief Article |
Aug 1, 2002 |
875 |
| GeneLink, Unicity Network sign agreement. (Industry News). |
|
Brief Article |
Jun 1, 2002 |
59 |
| AltaRex and United Therapeutics sign license agreement. |
|
Brief Article |
Apr 1, 2002 |
765 |
| Collateral Therapeutics acquires rights to the EPAS1 gene. |
|
Brief Article |
Mar 1, 2002 |
212 |
| Ambion licenses RNA interference technology from MIT. |
|
Brief Article |
Mar 1, 2002 |
226 |
| MorphoSys and XOMA cross-license antibody technologies. |
|
Brief Article |
Feb 1, 2002 |
729 |
| Protein Design grants license to Celltech under patent. |
|
Brief Article |
Dec 1, 2001 |
251 |
| Lexicon grants patented gene targeting technology license to GlaxoSmithkline. |
|
Brief Article |
Aug 1, 2001 |
199 |
| Roche Diagnostics markets two new hepatitis C tests. |
|
Brief Article |
Aug 1, 2001 |
107 |
| Genemachines licenses microarray fabrication technology from Incyte. |
|
Brief Article |
Jul 1, 2001 |
238 |
| IMMUNEX LICENSES ROSETTA RESOLVER EXPRESSION DATA ANALYSIS. |
|
|
Apr 1, 2001 |
363 |
| Incyte licenses comprehensive microarray patent portfolio to Chiron. |
|
Brief Article |
Jan 1, 2001 |
325 |
| Abgenix extends antibody collaboration with Amgen. |
|
Brief Article |
Jan 1, 2001 |
182 |
| King Pharmaceuticals announces exclusive license for papillomavirus vaccines with Novavax. |
|
Brief Article |
Dec 1, 2000 |
728 |
| Xenobiotic Detection Systems. |
|
Brief Article |
Dec 1, 2000 |
41 |
| Akkadix acquires exclusive license to Pangene's enhanced homologous recombination technologies for plant science applications. |
|
Brief Article |
Sep 1, 2000 |
663 |
